Bruker Announces that Institute Director, Biopharma Entrepreneur and Immunology Leader Dr. Eicke Latz will join its Board of Directors
The 5 most interesting analyst questions from Bruker’s Q3 2026 earnings call
Bruker Corporation 2026 Q3 - Results - Earnings Call Presentation
Bruker: Five Quarters Of Orders Are Still Waiting To Show Up In Revenue
Citigroup Maintains Neutral on Bruker, Raises Price Target to $64
Leerink Partners Maintains Outperform on Bruker, Raises Price Target to $85
Bruker Stock Earnings Beat Has The Bull Case Changed?
Bruker (BRKR) Jumped, What Is Behind The Fresh Attention?
Bruker Corp (BRKR) Q3 2026 Earnings Call Highlights: Margin Expansion and Strong Bookings ...
Bruker (BRKR) Q3 2026 Earnings Call Transcript
Bruker Corporation (BRKR) Q3 2026 Earnings Call Transcript
Bruker Corporation Q3 2026 Earnings Call Summary
Bruker Q3 Earnings Call Highlights
Here's What Key Metrics Tell Us About Bruker (BRKR) Q3 Earnings
BRUKER CORP (NASDAQ:BRKR) Q3 EPS Beat and Margin Expansion Offset Slight Revenue Miss
Bruker (BRKR) Q3 Earnings and Revenues Surpass Estimates
Bruker (NASDAQ:BRKR) surprises with Q3 2026 sales, stock soars
Bruker: Q3 Earnings Snapshot
Bruker Reports Third Quarter 2026 Financial Results
Bruker Q3 2026 Earnings Call Transcript
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.